$5.2m to University of Helsinki-led Study Targeting Metastatic Breast Cancer

Academic research centers from Finland and California come together thanks to a Department of Defense Breast Cancer Research Program (BRCP) Breakthrough Award to help advance breast cancer research while supporting tighter ties between the Scandinavian and California investigators.  Thanks to $5.2 million from the U.S. Department of Defense the University of Helsinki in partnership with University of California, San Francisco lead a study involving teams of researchers, clinicians and advocates the investigation into how the MYC oncogene can regulate an anti-tumor immune response and hopefully leading to novel therapeutic approaches targeting aggressive breast cancers.

The Yin and Yang of MYC Oncogene

While some cancer genes support cancerous growth, they also contribute to vulnerabilities in the same cancer cells which the Finish and Californian team hope to exploit with novel therapies. For example, in breast cancer MYC cancer gene reprograms cells to grow without pause however this uncontrolled growth renders MYC carrying cancer cells prey to a number of drugs.

Quest for Precision

Highlighting the opportunity, Juha Klefstrom, PhD from University of Helsinki rec...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee